The centrosome as potential target for cancer therapy and prevention

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Expert opinion on therapeutic targets

• Publication date

  2013-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/14728222.2013.731396PMID 23062185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy

  2012cited by this paper
• Breaking the ties that bind: New advances in centrosome biology

  2012cited by this paper
• Aurora kinase inhibitors: Progress towards the clinic

  2012cited by this paper
• BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application

  2012cited by this paper
• GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivo.

  2012cited by this paper
• The centrosome cycle: Centriole biogenesis, duplication and inherent asymmetries

  2011cited by this paper
• Aurora-A inactivation causes mitotic spindle pole fragmentation by unbalancing microtubule-generated forces

  2011cited by this paper
• Discovery of (+)-N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a kinesin spindle protein inhibitor and potential anticancer agent.

  2011cited by this paper
• Differential control of Eg5-dependent centrosome separation by Plk1 and Cdk1

  2011cited by this paper
• The conversion of centrioles to centrosomes: essential coupling of duplication with segregation

  2011cited by this paper
• Single-Cell Analysis of Ploidy and Centrosomes Underscores the Peculiarity of Normal Hepatocytes

  2011cited by this paper
• Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays

  2011cited by this paper
• Anaphase Catastrophe Is a Target for Cancer Therapy

  2011cited by this paper
• Centrosome clustering and chromosomal (in)stability: A matter of life and death

  2011cited by this paper
• The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression

  2011cited by this paper
• Nek9 is a Plk1‐activated kinase that controls early centrosome separation through Nek6/7 and Eg5

  2011cited by this paper
• Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer

  2011cited by this paper
• Update on aurora kinase targeted therapeutics in oncology

  2011cited by this paper
• A Clinical Overview of Centrosome Amplification in Human Cancers

  2011cited by this paper
• Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.

  2011cited by this paper
• Cleavage of cohesin rings coordinates the separation of centrioles and chromatids

  2011cited by this paper
• Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies

  2011cited by this paper
• A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors.

  2011cited by this paper
• Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor

  2010cited by this paper
• Plk4 trans-autophosphorylation regulates centriole number by controlling βTrCP-mediated degradation

  2010cited by this paper
• Daughter Centriole Elongation Is Controlled by Proteolysis

  2010cited by this paper
• Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction

  2010influential reference
• AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders

  2010cited by this paper
• Proteins Required for Centrosome Clustering in Cancer Cells

  2010cited by this paper
• Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL-positive leukemic cells.

  2010cited by this paper
• Cep152 acts as a scaffold for recruitment of Plk4 and CPAP to the centrosome

  2010influential reference
• Merotelic attachments and non-homologous end joining are the basis of chromosomal instability

  2010cited by this paper
• Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology.

  2009cited by this paper
• Plk1-Dependent Recruitment of γ-Tubulin Complexes to Mitotic Centrosomes Involves Multiple PCM Components

  2009cited by this paper
• Cell cycle kinases as therapeutic targets for cancer

  2009cited by this paper
• Polo kinase and separase regulate the mitotic licensing of centriole duplication in human cells.

  2009influential reference
• A Mechanism Linking Extra Centrosomes to Chromosomal Instability

  2009cited by this paper
• Centrosomal Aki1 and cohesin function in separase-regulated centriole disengagement

  2009cited by this paper
• The SCF/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK/PLK4.

  2009cited by this paper
• The SCFSlimb ubiquitin ligase regulates Plk4/Sak levels to block centriole reduplication

  2009cited by this paper
• Cullin 1 functions as a centrosomal suppressor of centriole multiplication by regulating polo-like kinase 4 protein levels.

  2009cited by this paper
• Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion

  2008cited by this paper
• Polo and Aurora kinases: lessons derived from chemical biology.

  2008cited by this paper
• Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes.

  2008cited by this paper
• Concerning the Origin of Malignant Tumours by Theodor Boveri. Translated and annotated by Henry Harris

  2008cited by this paper
• Control of daughter centriole formation by the pericentriolar material

  2008cited by this paper
• Analysis of centrosome overduplication in correlation to cell division errors in high-risk human papillomavirus (HPV)-associated anal neoplasms.

  2008cited by this paper
• Structure and duplication of the centrosome

  2007influential reference
• [Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen].

  2007cited by this paper
• P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models

  2007cited by this paper
• Plk4-induced centriole biogenesis in human cells.

  2007cited by this paper
• Mitotic regulation by NIMA-related kinases

  2007cited by this paper
• BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.

  2007cited by this paper
• A Phase I Pharmacokinetic Study of HMN-214, a Novel Oral Stilbene Derivative with Polo-Like Kinase-1–Interacting Properties, in Patients with Advanced Solid Tumors

  2006cited by this paper
• Mechanism limiting centrosome duplication to once per cell cycle

  2006influential reference
• NDEL1 Phosphorylation by Aurora-A Kinase Is Essential for Centrosomal Maturation, Separation, and TACC3 Recruitment

  2006cited by this paper
• Normal Cells, but Not Cancer Cells, Survive Severe Plk1 Depletion

  2006cited by this paper
• In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials

  2006cited by this paper
• Monastrol Inhibition of the Mitotic Kinesin Eg5*

  2005cited by this paper
• The Polo kinase Plk4 functions in centriole duplication

  2005cited by this paper
• The forkhead-associated domain protein Cep170 interacts with Polo-like kinase 1 and serves as a marker for mature centrioles.

  2005cited by this paper
• ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent.

  2005cited by this paper
• Spindle Multipolarity Is Prevented by Centrosomal Clustering

  2005cited by this paper
• Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.

  2005cited by this paper
• Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals.

  2005cited by this paper
• Flavopiridol: the First Cyclin-Dependent Kinase Inhibitor in Human Clinical Trials

  2004cited by this paper
• Cyclin-dependent kinase inhibitor indirubin-3′-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies

  2004cited by this paper
• N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent.

  2004cited by this paper
• Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins

  2004cited by this paper
• Centrosome abnormalities and genomic instability induced by human papillomavirus oncoproteins.

  2003cited by this paper
• Excessive centrosome abnormalities without ongoing numerical chromosome instability in a Burkitt's lymphoma

  2003cited by this paper
• Self-organisation and forces in the microtubule cytoskeleton.

  2003cited by this paper
• Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphoma?

  2003cited by this paper
• Proliferation of cancer cells despite CDK2 inhibition.

  2003cited by this paper
• Centrosome aberrations: cause or consequence of cancer progression?

  2002cited by this paper
• Rootletin, a novel coiled-coil protein, is a structural component of the ciliary rootlet

  2002cited by this paper
• Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability

  2002cited by this paper
• Amplified Centrosomes in Breast Cancer: A Potential Indicator of Tumor Aggressiveness

  2002cited by this paper
• Centrosome amplification drives chromosomal instability in breast tumor development

  2002cited by this paper
• Segregating Sister Genomes: The Molecular Biology of Chromosome Separation

  2002cited by this paper
• Centrosome abnormalities, genomic instability and carcinogenic progression.

  2001cited by this paper
• Kendrin/pericentrin-B, a centrosome protein with homology to pericentrin that complexes with PCM-1.

  2001cited by this paper
• Derivation of human tumor cells in vitro without widespread genomic instability.

  2001cited by this paper
• Centrosome Abnormalities and Genomic Instability by Episomal Expression of Human Papillomavirus Type 16 in Raft Cultures of Human Keratinocytes

  2001cited by this paper
• Managing the centrosome numbers game: from chaos to stability in cancer cell division.

  2001cited by this paper
• Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression.

  2001cited by this paper
• Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype.

  2001cited by this paper
• Centrosome-independent mitotic spindle formation in vertebrates.

  2000cited by this paper
• The Respective Contributions of the Mother and Daughter Centrioles to Centrosome Activity and Behavior in Vertebrate Cells

  2000cited by this paper
• The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle.

  2000influential reference
• Probing Spindle Assembly Mechanisms with Monastrol, a Small Molecule Inhibitor of the Mitotic Kinesin, Eg5

  2000cited by this paper
• Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen.

  1999cited by this paper
• Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

  1999cited by this paper
• Centrosome defects and genetic instability in malignant tumors.

  1998cited by this paper
• Expanding the role of HsEg5 within the mitotic and post-mitotic phases of the cell cycle.

  1998cited by this paper
• Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity.

  1998cited by this paper
• A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

  1998cited by this paper
• C-Nap1, a Novel Centrosomal Coiled-Coil Protein and Candidate Substrate of the Cell Cycle–regulated Protein Kinase Nek2

  1998cited by this paper
• Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

  1998cited by this paper
• A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines

  1997cited by this paper

• Development of a novel centrosome-related risk signature to predict prognosis and treatment response in lung adenocarcinoma

  2024cites this paper
• Synthesis and Evaluation of Novel Carboxamides Capable of Causing Centrosome Declustering and Apoptosis in Breast Cancer Cells

  2022cites this paper
• DGAT1 Inhibitor Suppresses Prostate Tumor Growth and Migration by Regulating Intracellular Lipids and Non-Centrosomal MTOC Protein GM130

  2019cites this paper
• Clinically Applicable Inhibitors Impacting Genome Stability

  2018cites this paper
• Novel insight into the function of tankyrase

  2018cites this paper
• Tankyrase: Function and Tankyrase Inhibitor in Cancer

  2018cites this paper
• The Role of Hsp70 and Nek6 in Centrosome Clustering in Cancer Cells

  2017cites this paper
• Illuminating Actionable Biology in Breast Cancer: Novel Predictive and Prognostic Biomarkers

  2017cites this paper
• Design, Synthesis, and Cytotoxicity Evaluation of Novel Griseofulvin Analogues with Improved Water Solubility

  2017cites this paper
• Stat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1

  2017cites this paper
• Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer

  2017cites this paper
• Synthesis and formulation studies of griseofulvin analogues with improved solubility and metabolic stability.

  2017cites this paper
• Centrosome amplification: a suspect in breast cancer and racial disparities.

  2017cites this paper
• Centrosomal clustering contributes to chromosomal instability and cancer.

  2016cites this paper
• A novel role for the deubiquitinase USP1 in the control of centrosome duplication

  2016cites this paper
• Asterless is required for centriole length control and sperm development

  2016cites this paper
• miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110

  2016cites this paper
• Phosphorylation Sites Mediate Anaphase Catastrophe after CDK 2 Inhibition : Evidence for Cooperationwith USP 33 Knockdown

  2015cites this paper
• UC Davis UC Davis Previously Published Works Title The Aspergillus

  2015cites this paper
• The Aspergillus nidulans bimC4 mutation provides an excellent tool for identification of kinesin-14 inhibitors.

  2015cites this paper
• Dis-organizing centrosomal clusters: specific cancer therapy for a generic spread?

  2015cites this paper
• Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown

  2015cites this paper
• Disruption of spindle pole symmetry by centriole overduplication induces chromosome instability in human malignancies

  2015cites this paper
• Plk 4 : prognostic markers , drivers of breast tumorigenesis and drug resistance

  2014cites this paper
• Tankyrases: Structure, Function and Therapeutic Implications in Cancer

  2014cites this paper
• Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death

  2014cites this paper
• Exposure to Bisphenol A Correlates with Early-Onset Prostate Cancer and Promotes Centrosome Amplification and Anchorage-Independent Growth In Vitro

  2014cites this paper
• A 3′UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1

  2014cites this paper
• Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance.

  2014cites this paper
• Centrosomes and the art of mitotic spindle maintenance.

  2014cites this paper
• Centrosomal abnormalities characterize human and rodent cystic cholangiocytes and are associated with Cdc25A overexpression.

  2014cites this paper
• [The role of centrosomes in cells and their potential contribution to carcinogenesis].

  2014cites this paper
• Characterisation of APC localisation, dynamics and functions at the centrosome

  2014cites this paper
• Mitochondrial genome regulates mitotic fidelity by maintaining centrosomal homeostasis

  2014cites this paper
• Centrosome Dysfunction Contributes to Chromosome Instability, Chromoanagenesis, and Genome Reprograming in Cancer

  2013cites this paper
• RNA-binding protein RBM8A (Y14) and MAGOH localize to centrosome in human A549 cells

  2013cites this paper
• Optimizing experimental radioimmunotherapy : investigating the different mechanisms behind radiation induced cell deaths

  2013cites this paper
• Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1.

  2013cites this paper
• Methods and benefits of imaging the temperature distribution inside living cells

  2013cites this paper
• Centrosome Dysfunction Contributes to Chromosome Instability, Chromoanagenesis, and Genome Reprograming in Cancer

  year unknowncites this paper